Lena A Ohannesian

Title: Innovator Spotlight: Lena A. Ohannesian

Introduction

Lena A. Ohannesian is a notable inventor based in Blue Bell, Pennsylvania. With one registered patent to her name, she has contributed significantly to the field of pharmaceuticals, particularly in enhancing the properties of acetaminophen.

Latest Patents

Lena's most prominent patent is focused on the development of alkali metal and alkaline-earth metal salts of acetaminophen. This innovative approach involves isolating salts formed by reacting the free acid of acetaminophen with the corresponding metal hydroxide. The resulting salts have demonstrated superior water solubility and a less bitter taste compared to the free acid form. These advancements have potential applications in combination with other active ingredients, enhancing the overall efficacy and appeal of acetaminophen-based medications.

Career Highlights

Lena is currently employed at McNeil-PPC, Inc., where she applies her expertise in pharmaceutical sciences. Her work is characterized by a dedication to improving medication formulations that benefit consumers and healthcare providers alike. Her innovative spirit and commitment to research have earned her recognition in her field.

Collaborations

Throughout her career, Lena has collaborated with notable colleagues such as David Nadig and John D. Higgins, III. These collaborations have fostered a dynamic exchange of ideas and research, contributing to the successful development and patenting of her inventions.

Conclusion

Lena A. Ohannesian exemplifies the impact of innovation in the pharmaceutical industry. Her work on the alkali metal and alkaline-earth metal salts of acetaminophen represents a significant step forward in medication formulation, benefiting both patients and healthcare providers. As she continues her work at McNeil-PPC, Inc., the potential for further advancements in her field remains promising.